Raisio Benecol Ltd.

Raisio Nutrition Ltd

Tatu Miettenen

Ingmar Wester

Hannu Vanhanen

The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble &#x3b2;-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the &#x3b2;-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.

Substance for lowering high cholesterol level in serum and methods for preparing and using the same

The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble &bgr;-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the &bgr;-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.

The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble .beta.-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the .beta.-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.

Growing community of inventors

Espoo, Finland

Tatu Miettenen